<code id='E91A714B6B'></code><style id='E91A714B6B'></style>
    • <acronym id='E91A714B6B'></acronym>
      <center id='E91A714B6B'><center id='E91A714B6B'><tfoot id='E91A714B6B'></tfoot></center><abbr id='E91A714B6B'><dir id='E91A714B6B'><tfoot id='E91A714B6B'></tfoot><noframes id='E91A714B6B'>

    • <optgroup id='E91A714B6B'><strike id='E91A714B6B'><sup id='E91A714B6B'></sup></strike><code id='E91A714B6B'></code></optgroup>
        1. <b id='E91A714B6B'><label id='E91A714B6B'><select id='E91A714B6B'><dt id='E91A714B6B'><span id='E91A714B6B'></span></dt></select></label></b><u id='E91A714B6B'></u>
          <i id='E91A714B6B'><strike id='E91A714B6B'><tt id='E91A714B6B'><pre id='E91A714B6B'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:fashion    Page View:29452
          Calling Bullshit course University of Washington
          Screenshot via callingbullshit.org

          Tired of alternative facts, fake news, and breathless hyperbole, two professors at the University of Washington are trying to strike a blow for science.

          Their weapon? A new course: “Calling Bullshit In the Age of Big Data.”

          advertisement

          The class website and colorful syllabus went online last month and almost instantly went viral.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more
          What Congress can do to address the rural doctor shortage
          What Congress can do to address the rural doctor shortage

          AdobeThepressuresofthelastthreeandahalfyearshaveaffectedeverycornerofthehealthcarelandscape,butnowhe

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Xenotransplantation trials will require adjusting expectations, experts say

          RobertMontgomeryofNewYorkUniversityspeaksasMeganSykesofColumbiaUniversityandInsooHyunofHarvardMedica